학술논문

Subcutaneous Tanezumab vs NSAID for the Treatment of Osteoarthritis: Efficacy and General Safety Results from a Randomized, Double-Blind, Active-Controlled, 80-Week, Phase-3 Study
Document Type
Journal
Source
ARTHRITIS & RHEUMATOLOGY; OCT 2019, 71 3p. Supplement: 10
Subject
Language
English
ISSN
23265205